Skip to main content

Advertisement

Log in

Cross-regional Pharmaceutical Technology Transfer in China: Patterns and Proposed Investment Strategies

  • Global Health
  • Published:
Therapeutic Innovation & Regulatory Science Aims and scope Submit manuscript

Abstract

The Chinese pharmaceutical market is undergoing dramatic growth, with a huge population, urbanization, a growing number of elderly patients, and increases in the standard of living. As a research-based and high-tech sector, the pharmaceutical industry depends highly upon technological innovation, especially the spatial diffusion of technologies from the perspective of economic geography. In this context, an analysis of technology flowing between regions is of great significance for the investment in a regional market. This article differs from previous studies by focusing on geographic patterns of pharmaceutical technology transfer captured by patent licensing in China, which are further used to analyze investment strategies. The research sample is composed of all pharmaceutical patent licenses filed with the State Intellectual Property Office of China from January 1, 2009, through December 31, 2012. As a result, a geographic network of pharmaceutical technology diffusion in China could be visualized, and province-level regions were ranked and classified into 3 types—input, output, and balance—by various network indicators. Finally, potential investment strategies on different types of regions are recommended for firms abroad, technology holders, contract research organizations, and technology agencies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Liu H, Jiang YZH. Technology transfer from higher education institutions to industry in China: nature and implications. Technovation. 2001;21:175–188.

    Article  Google Scholar 

  2. Morrison WM. China’s economic rise: history, trends, challenges, and implications for the United States. Congressional Research Service. 2013;3:1.

    Google Scholar 

  3. Reuters. Reuters’ report [in Chinese]. https://cn.reuters.com/article/CNTechNews/idCNCHINA-252052010062. Accessed March 16, 2013.

  4. Ministry of Science and Technology of the People’s Republic of China. Analysis on science and technology articles of China in 2011. Science and technology statistics report. https://www.sts.org.cn/tjbg/cgylw/documents/2012/20130123.htm. Published 2012. Accessed March 16, 2013.

  5. Link AN, Siegel DS, Bozeman B. An empirical analysis of the propensity of academics to engage in informal university technology transfer. Industrial and Corporate Change. 2007;16:641–655.

    Article  Google Scholar 

  6. Farris GF. Research on innovation management and technology transfer in China. Techno Transfer. 2007;32:123–126.

    Article  Google Scholar 

  7. Aida C, Olivier D. Performance of Spanish universities in technology transfer: an empirical analysis. Res Policy. 2010;39:1160–1173.

    Article  Google Scholar 

  8. Akhavan AN, Bagheri A, Jabbari N. An empirical studying of barriers for technology transfer: the case of Iran. In: Proceedings of the 2008 IEEE ICMIT; 2008:92–97. doi:https://doi.org/10.1109/ICMIT.2008.4654343.

  9. Sun LX, Hong E, Li T. Incorporating technology diffusion, factor mobility and structural change into cross-region growth regression: an application to China. J Reg Sci. 2010;50:734–755.

    Article  Google Scholar 

  10. Chyi YL, Lai YM, Liu WH. Knowledge spillovers and firm performance in the high-technology industrial cluster. Res Policy. 2012;41:556–564.

    Article  Google Scholar 

  11. Sanchez M, Criado O, Valentin M. Effects of knowledge spillovers on innovation and collaboration in science and technology parks. Journal of Knowledge Management. 2011;15:948–970.

    Article  Google Scholar 

  12. Hu YJ, Franny G, Bian Y, et al. The Chinese pharmaceutical market: perspectives of the health consumer. Journal of Medical Marketing. 2007;7:295–300.

    Article  Google Scholar 

  13. IMS Health. IMS market prognosis 2011–2015. https://www.imshealth.com. Published September 2011. Accessed March 16, 2013.

  14. Li Y, Xu GB, Yu LY. Study on the cluster development model of bio-pharmaceutical industry in China. In: Proceedings of the 2nd International Conference on Product Innovation Management & the 3rd International Conference on Value Engineering; 2007:196–201.

  15. Hu YJ, Bian Y, Wang YT. Opening the black box of pharmaceutical patent value: an empirical analysis. Drug Inf J. 2008;42:561–568.

    Article  Google Scholar 

  16. Hu YJ, Bian Y, Wang YT. The Chinese pharmaceutical market: dynamics and a proposed investment strategy. Journal of Medical Marketing. 2007;7:18–24.

    Article  Google Scholar 

  17. Zhao JP, Feng G. Analysis on pharmaceutical industry R&D status and bottleneck in China. Modern Business Trade Industry. 2012;8:25–26.

    Google Scholar 

  18. Rui GZH, Lin G, Zhang HB, et al. Bio-pharmaceutical in Beijing: analysis on R&D outsourcing services and technology market. Industry & Marketing. 2009;3:11–19.

    Google Scholar 

  19. Wang ML, Zhang S, Wang XW. The global pharmaceutical industry and China’s position. In: WTO, Globalization and China’s Health Care System. New York, NY: Palgrave Macmillan; 2007:55–85.

    Chapter  Google Scholar 

  20. Zhang R, Muo RH. The empirical analysis on the relationship between S&T progress and company performance of the listed companies in pharmaceutical industry in China. In: Conference on WEB Based Business Management; 2010:1030–1035.

  21. Cui L, Dong J, Chai YT. Quantitative studies on the organizational structure of SME’s: a case study of the pharmaceutical industry in China. In: Proceedings of the 2006 Winter Simulation Conference; 2006:2289.

  22. O’Neale DRJ, Hendy SC. Power law distributions of patents as indicators of innovation. PLoS One. 2012;7:1–9.

    Article  Google Scholar 

  23. Shi XP. Patent licensing for technology-transfer: an integrated structural model for research. Int J Technol Manag. 1995;10:921–940.

    Google Scholar 

  24. Baldini N. University patenting and licensing activity: a review of the literature. Res Eval. 2006;15:197–207.

    Article  Google Scholar 

  25. State Intellectual Property Office of the People’s Republic of China. Patent license contract for record management. https://www.sipo.gov.cn/zcfg/flfg/zl/bmgz/200804/t20080403_369107.html. Accessed March 16, 2013.

  26. Knoke D, Yang S. Social Network Analysis. Thousand Oaks, CA: SAGE Publications; 2008.

    Book  Google Scholar 

  27. Kadushin C. Understanding Social Networks: Theories, Concepts, and Findings. Oxford: Oxford University Press; 2012.

    Google Scholar 

  28. Higham DJ, Kibble MA. Unified View of Spectral Clustering [Mathematics research report 02]. Glasgow, Scotland: University of Strathclyde; 2004.

    Google Scholar 

  29. Blondel VD, Guillaume JL, Lambiotte R, et al. Fast unfolding of communities in large networks. Journal of Statistical Mechanics: Theory and Experiment. 2008;10:2–12.

    Google Scholar 

  30. Leydesdorff L. On the normalization and visualization of author co-citation data: Salton’s cosine versus the Jaccard index. J Am Soc Inf Sci Technol. 2008;59:77–85.

    Article  Google Scholar 

  31. Wasserman S, Faust K. Social Network Analysis: Methods and Applications. Cambridge, UK: Cambridge University Press; 1994.

    Book  Google Scholar 

  32. Heller-Schuh SB, Barber M, Henriques L, et al. Analysis of Networks in European Framework Programmes (1984–2006). Sevilla, Spain: European Commission; 2011.

    Google Scholar 

  33. Scherngell T, Hu YJ. Collaborative knowledge production in China: regional evidence from a gravity model approach. Reg Stud. 2011;45:755–772.

    Article  Google Scholar 

  34. National Bureau of Statistics of China, Ministry of Science and Technology of China. 2010 national science and technology funds invested statistical bulletin. https://www.stats.gov.cn:82/tjgb/rdpcgb/qgrdpcgb/t20110928_402756933.htm. Accessed March 26, 2013.

  35. China Investment Consulting. Jiangsu pharmaceutical industry research report. https://www.ewise.com.cn/Industry/201304/yiyao151527.htm. Accessed March 26, 2013.

  36. Science Technology Department of Jiangsu Province. Jiangsu Province pharmaceutical industry development plan (2009–2012). https://www.jstd.gov.cn/upfile/File/201006/02/15393916.doc. Accessed March 26, 2013.

  37. Simcere Pharmaceutical Group. https://www.simcere.com/english2009/about/about.asp. Accessed March 26, 2013.

  38. Guangdong Food and Drug Administration. Pharmaceutical industry development report in Guangdong Province. https://zwgk.gd.gov.cn/00694124X/201210/t20121010_348334.html. Accessed March 26, 2013.

  39. Guangzhou Pharmaceutical Company Limited. https://www.gzphar.com.cn/about/about.asp?id=1164&typeid=131. Accessed March 16, 2013.

  40. Shandong Economic and Information Technology Commission. Shandong Province pharmaceutical industry development plan. https://www.zjb.gov.cn/E_ReadNews.asp?ArticleID=3618. Accessed March 16, 2013.

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yuanjia Hu PhD or Ling Su PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ni, J., Xu, J., Hu, Y. et al. Cross-regional Pharmaceutical Technology Transfer in China: Patterns and Proposed Investment Strategies. Ther Innov Regul Sci 48, 226–235 (2014). https://doi.org/10.1177/2168479013506003

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/2168479013506003

Keywords

Navigation